AU2001236001A1 - Immune enhancement compositions and use thereof - Google Patents
Immune enhancement compositions and use thereofInfo
- Publication number
- AU2001236001A1 AU2001236001A1 AU2001236001A AU3600101A AU2001236001A1 AU 2001236001 A1 AU2001236001 A1 AU 2001236001A1 AU 2001236001 A AU2001236001 A AU 2001236001A AU 3600101 A AU3600101 A AU 3600101A AU 2001236001 A1 AU2001236001 A1 AU 2001236001A1
- Authority
- AU
- Australia
- Prior art keywords
- immune enhancement
- enhancement compositions
- compositions
- immune
- enhancement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000055019 | 2000-02-29 | ||
JP2000-55019 | 2000-02-29 | ||
US25374400P | 2000-11-29 | 2000-11-29 | |
US60253744 | 2000-11-29 | ||
PCT/JP2001/001512 WO2001064245A1 (en) | 2000-02-29 | 2001-02-28 | Immune enhancement compositions and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001236001A1 true AU2001236001A1 (en) | 2001-09-12 |
Family
ID=26586479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001236001A Abandoned AU2001236001A1 (en) | 2000-02-29 | 2001-02-28 | Immune enhancement compositions and use thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1264600A4 (en) |
AU (1) | AU2001236001A1 (en) |
CA (1) | CA2401352A1 (en) |
WO (1) | WO2001064245A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4111856B2 (en) | 2002-04-12 | 2008-07-02 | 昭和電工株式会社 | Stabilized ascorbic acid derivatives |
JP2006143661A (en) * | 2004-11-19 | 2006-06-08 | Nippon Menaade Keshohin Kk | Nf kappa b inhibitor |
WO2007070981A1 (en) * | 2005-12-23 | 2007-06-28 | Vital Health Sciences Pty Ltd | Compounds having cytokine modulating properties |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02209807A (en) * | 1989-02-09 | 1990-08-21 | Takeda Chem Ind Ltd | Anti-inflammatory agent |
US5114957A (en) * | 1990-05-08 | 1992-05-19 | Biodor U.S. Holding | Tocopherol-based antiviral agents and method of using same |
WO1995028925A1 (en) * | 1994-04-27 | 1995-11-02 | Seiichi Tanuma | Disease preventive/remedy |
JPH10155429A (en) * | 1996-11-27 | 1998-06-16 | Showa Denko Kk | Method for supplying vitamin e to animals and tocopherol phosphate for animals or its salts composition |
EP0875246A1 (en) * | 1997-04-04 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer |
JPH10298174A (en) * | 1997-04-30 | 1998-11-10 | Showa Denko Kk | Ascorbic acid derivative and vitamin c agent containing the same |
JP3772468B2 (en) * | 1997-06-11 | 2006-05-10 | 昭和電工株式会社 | L-ascorbic acid-2-phosphate zinc salt and method for producing the same |
-
2001
- 2001-02-28 WO PCT/JP2001/001512 patent/WO2001064245A1/en active Application Filing
- 2001-02-28 CA CA002401352A patent/CA2401352A1/en not_active Abandoned
- 2001-02-28 EP EP01908150A patent/EP1264600A4/en not_active Ceased
- 2001-02-28 AU AU2001236001A patent/AU2001236001A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1264600A4 (en) | 2004-11-17 |
CA2401352A1 (en) | 2001-09-07 |
WO2001064245A1 (en) | 2001-09-07 |
EP1264600A1 (en) | 2002-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001294814A1 (en) | Pumpcn compositions and uses thereof | |
AU2002357119A1 (en) | Mitocidal compositions and methods | |
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
AU2001250875A1 (en) | Anti-microbial and immunostimulating composition | |
AU2002211717A1 (en) | Stresscopins and their uses | |
AU2002220419A1 (en) | Prolamin-based sustained-release compositions and delayed-onset compositions | |
AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
AU2001276461A1 (en) | Cleaning compositions and their use | |
AU4834200A (en) | Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof | |
AU2001240018A1 (en) | Adeno-associated viral compositions and methods | |
AU2001229439A1 (en) | Bioconjugates and uses thereof | |
AU1152601A (en) | Compositions and their use | |
GB0027391D0 (en) | Films and compositions | |
AU2001233086A1 (en) | Ceramidase compositions and methods based thereon | |
AU2001253481A1 (en) | Methods and compositions for eleciting an immune response | |
GB9922135D0 (en) | Compositions and uses | |
AU8975701A (en) | Novel composition and use | |
AU2001236001A1 (en) | Immune enhancement compositions and use thereof | |
AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof | |
AU2001262928A1 (en) | Pharmaceutical compositions and their use | |
AU2001239954A1 (en) | Cleaning compositions and use thereof | |
AU2000251520A1 (en) | Antiviral methods and compositions | |
AU2002359869A1 (en) | Pak5-related compositions and methods | |
AU5104101A (en) | Composition and use | |
AUPQ723300A0 (en) | Compositions and uses therefor - III |